99 related articles for article (PubMed ID: 8960523)
21. Dose distribution along the transverse axis of a new 125I source for interstitial brachytherapy.
Nath R; Yue N
Med Phys; 2000 Nov; 27(11):2536-40. PubMed ID: 11128306
[TBL] [Abstract][Full Text] [Related]
22. Calculation of dose distribution near an innovative concentric balloon catheter for endovascular brachytherapy.
Xu Z; Yang G; Reinstein LE; Cole PE
Cardiovasc Radiat Med; 2000; 2(1):26-31. PubMed ID: 11229058
[TBL] [Abstract][Full Text] [Related]
23. Monte Carlo calculations of dose distributions around 32P and 198Au stents for intravascular brachytherapy.
Reynaert N; Verhaegen F; Taeymans Y; Van Eijkeren M; Thierens H
Med Phys; 1999 Aug; 26(8):1484-91. PubMed ID: 10501047
[TBL] [Abstract][Full Text] [Related]
24. Dosimetry of a W-188/Re-188 beta line source for endovascular brachytherapy.
Häfeli UO; Roberts WK; Meier DS; Ciezki JP; Pauer GJ; Lee EJ; Weinhous MS
Med Phys; 2000 Apr; 27(4):668-75. PubMed ID: 10798688
[TBL] [Abstract][Full Text] [Related]
25. Dosimetry of a radioactive coronary balloon dilatation catheter for treatment of neointimal hyperplasia.
Amols HI; Reinstein LE; Weinberger J
Med Phys; 1996 Oct; 23(10):1783-8. PubMed ID: 8946374
[TBL] [Abstract][Full Text] [Related]
26. Design and dosimetry of a novel 90Y beta source to prevent restenosis after angioplasty.
Mück K; Schmidt W; Wexberg P; Görz W; Maurer G; Gottsauner-Wolf M
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):249-55. PubMed ID: 10656399
[TBL] [Abstract][Full Text] [Related]
27. The transit dose component of high dose rate brachytherapy: direct measurements and clinical implications.
Bastin KT; Podgorsak MB; Thomadsen BR
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):695-702. PubMed ID: 8331003
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric penumbra effects in catheter-based intravascular brachytherapy using a centered photon or beta line source.
Yue N; Nath R; Roberts K
Cardiovasc Radiat Med; 2000; 2(1):32-8. PubMed ID: 11229060
[TBL] [Abstract][Full Text] [Related]
29. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
Selvam TP; Sahoo S; Vishwakarma RS
Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
[TBL] [Abstract][Full Text] [Related]
30. Endovascular brachytherapy in coronary arteries: the Rotterdam experience.
Coen VL; Knook AH; Wardeh AJ; van der Giessen WJ; De Pan C; Sipkema D; Marijnissen JP; Sabaté M; den Boer A; Serruys PW; Levendag PC
Cardiovasc Radiat Med; 2000; 2(1):42-50. PubMed ID: 11229062
[TBL] [Abstract][Full Text] [Related]
31. The impact of stent design and delivery upon the long-term efficacy of radioisotope stents.
Fischell TA; Hehrlein C; Fischell RE; Fischell DR
J Invasive Cardiol; 2000 Mar; 12(3):162-7. PubMed ID: 10731287
[TBL] [Abstract][Full Text] [Related]
32. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
Ho Than MT; Munro Iii JJ; Medich DC
J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
[TBL] [Abstract][Full Text] [Related]
33. Gadolinium-153 as a brachytherapy isotope.
Enger SA; Fisher DR; Flynn RT
Phys Med Biol; 2013 Feb; 58(4):957-64. PubMed ID: 23339848
[TBL] [Abstract][Full Text] [Related]
34. Monte Carlo dose characterization of a new 90Sr/90Y source with balloon for intravascular brachytherapy.
Wang R; Li XA; Lobdell J
Med Phys; 2003 Jan; 30(1):27-33. PubMed ID: 12557975
[TBL] [Abstract][Full Text] [Related]
35. Thermoluminescent dosimetry for 103Pd seeds (model 200) in solid water phantom.
Chiu-Tsao ST; Anderson LL
Med Phys; 1991; 18(3):449-52. PubMed ID: 1870488
[TBL] [Abstract][Full Text] [Related]
36. Advantages and limitations of radioactive stents.
Hehrlein C; Kübler W
Semin Interv Cardiol; 1997 Jun; 2(2):109-13. PubMed ID: 9546990
[TBL] [Abstract][Full Text] [Related]
37. Monte Carlo dosimetry of a new 192Ir pulsed dose rate brachytherapy source.
Karaiskos P; Angelopoulos A; Pantelis E; Papagiannis P; Sakelliou L; Kouwenhoven E; Baltas D
Med Phys; 2003 Jan; 30(1):9-16. PubMed ID: 12557972
[TBL] [Abstract][Full Text] [Related]
38. A retrospective analysis of catheter-based sources in intravascular brachytherapy.
DeCunha J; Janicki C; Enger SA
Brachytherapy; 2017; 16(3):586-596. PubMed ID: 28190783
[TBL] [Abstract][Full Text] [Related]
39. Post-stenting intravascular brachytherapy trials on hypercholesterolemic rabbits using 32P liquid sources: implications for prevention of in-stent restenosis.
Wilczek K; Walichiewicz P; Petelenz B; Jache W; Jochem J; Tomasik A; Bilski P; Snietura M; Wodniecki J
Cardiovasc Intervent Radiol; 2002; 25(4):307-13. PubMed ID: 12042990
[TBL] [Abstract][Full Text] [Related]
40. Rectal thermoluminescent dosimeter measurements using the MicroSelectron High Dose Rate afterloader in postoperative intravaginal radiation cases.
Kessaris N; Nori D
Int J Radiat Oncol Biol Phys; 1993 May; 26(2):341-5. PubMed ID: 8491691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
